Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis

Over the past decade, the prevalence of infections involving methicillin-resistant Staphylococcus aureus (MRSA) in patients with cystic fibrosis (CF) has increased significantly. Tedizolid (TZD) demonstrates excellent activity against MRSA and a favorable safety profile. The pharmacokinetics of seve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Park, A young J., Wang, Joshua, Jayne, Jordanna, Fukushima, Lynn, Rao, Adupa P., D'Argenio, David Z., Beringer, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125567/
https://ncbi.nlm.nih.gov/pubmed/29914949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00550-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados